Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pieter, De Graeff"'
Autor:
Jonas Bergh, Paula van Hennik, Tomas Salmonson, Jan Sjöberg, Edward Laane, Kyriaki Tzogani, Christian Gisselbrecht, Pieter de Graeff, Francesco Pignatti, Ita Walsh, Annika Folin, Heinz Ludwig
Publikováno v:
The Oncologist
This article summarizes the scientific review of panobinostat that led to regulatory approval in the European Union.
On August 28, 2015, a marketing authorization valid through the European Union was issued for panobinostat, in combination with
On August 28, 2015, a marketing authorization valid through the European Union was issued for panobinostat, in combination with
Autor:
Edward Laane, Iordanis Gravanis, Pieter de Graeff, Petra Schmitt, Paula van Hennik, Christian Gisselbrecht, Jan Mueller-Berghaus, Kyriaki Tzogani, Francesco Pignatti, Lothar Bergmann, Tomas Salmonson
Publikováno v:
The Oncologist. 21:102-109
Background On October 25, 2012, a conditional marketing authorization valid throughout the European Union (EU) was issued for brentuximab vedotin for the treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL) and for the
Autor:
Ian, Graham, Chuck, Shear, Pieter, De Graeff, Caroline, Boulton, Alberico L, Catapano, Wendy Gattis, Stough, Stefan C, Carlsson, Guy, De Backer, Joseph, Emmerich, Scott, Greenfeder, Albert M, Kim, Dominik, Lautsch, Tu, Nguyen, Steven E, Nissen, Krishna, Prasad, Kausik K, Ray, Jennifer G, Robinson, William J, Sasiela, Karsten, Bruins Slot, Erik, Stroes, Tom, Thuren, Bart, Van der Schueren, Maja, Velkovski-Rouyer, Scott M, Wasserman, Olov, Wiklund, Emmanouil, Zouridakis, Cathrine, Thorstensen
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy, 4(2). Oxford University Press
The very high occurrence of cardiovascular events presents a major public health issue because treatment remains suboptimal. Lowering low-density lipoprotein cholesterol (LDL-C) with statins or ezetimibe in combination with a statin reduces major adv
Autor:
F. W. H. M. Merkus, F. W. J. Gribnau, Th. Thien, Hans W. Louwerenburg, J. Herre Kingma, Wiek H. van Gilst, A. Jacob Six, Pieter de Graeff, Harry Wesseling, J. R. BoeLaert, M. L. Schurgers, E. G. Matthys, F. Belpaire, R. F. Daneels, M. J. de Cre, M. G. Boqaert, P. C. D'Haese, G. A. Verpooten, L. V. Lamberts, L. Liang, M. E. de Broe, P. H. E. M. de Meijer, F. G. M. Russel, A. J. M. Russel, C. A. M. van Ginneken, B. M. van Liedekerke, W. E. Lambert, M. A. Yousouf, J. E. de Roose, A. P. de Leenheer, W. Lambert, J. de Bersaques, L. Vanneste, A. de Leenheer, S. de Marie, G. Slaghuis, P. M. Rozing, H. Mattie, F. G. J. Poelma, H. W. Hilbers, A. C. A. Jansen, J. J. Tukker, P. Augusti, N. Verbeke, A. van Peer, E. Snoeck, J. Heykants, J. Bruynseels, J. Peeters, W. Amery, V. Rogiers, Y. Vandenberghe, M. Comet, A. Callaerts, W. Sonck, A. Guillouzo, A. Vercruysse, P. van Rooy, N. Rombaut, G. vanden Bussche, A. C. I. T. L. Tan, T. L. Th. A. Jansen, E. F. S. Termond, P. W. C. Kloppenborg, Th. J. Benraad, V. van de Velde, R. Woestenbprghs, W. A. J. J. Hermens, S. G. Romeijn, M. J. M. Deurloo, G. Musch, D. L. Massart, M. van Hengstum, J. Festen, W. van den Broek, F. Corstens, C. Beurskens, M. Hankel, M. de Smet, S. J. P. van Belle, J. de May, G. A. Storme, P. J. K. Kuppen, H. Schuitemaker, L. J. van't Veer, A. T. van Oosterom, P. I. Schrier, E. A. de Bruijn, C. H. de Pooter, U. R. Tjaden, H. van Slooten, H. P. Roelevink, E. Smit, E. G. E. de Vries, J. Ijmker, D. R. A. Uges, M. Moors, K. Mertens, A. van Hecken, I. de Lepeleire, R. Verbesselt, T. B. Tjandra-Maga, P. J. de Schepper, P. J. M. Guelen, T. J. Jansen, W. P. Vrijhof, D. de Vos, S. Scharpé, R. Verkerk, N. Lsmeire, I. F. Zijlstra, F. M. Haaijer-Ruskamp, D. Post, P. F. Reddingius, H. Wesseling, H. C. H. Wollersheim, A. H. van den Meiracker, A. J. Man in 't Veld, P. Admiraal, F. Boomsma, F. Derkx, M. A. D. H. Schalekamp, D. F. Schoors, A. G. Dupont, F. Claessen, J. Reljenga, J. W. M. Lenders, Th. Thlen, G. Laekeman, L. Muylle, A. van Hoydonck, A. G. Herman, M. E. Peetermans
Publikováno v:
Pharmaceutisch Weekblad. 10:291-299